{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:52:22Z","timestamp":1790290342005,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.taap.2018.07.014","type":"journal-article","created":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T14:09:41Z","timestamp":1531836581000},"page":"65-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Comparative study of anti-VEGF Ranibizumab and Interleukin-6 receptor antagonist Tocilizumab in Adjuvant-induced Arthritis"],"prefix":"10.1016","volume":"356","author":[{"given":"Amany El-Shahawy","family":"Abdel-Maged","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany M.","family":"Gad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal Kamal","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad M.","family":"Aboulwafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0253-8280","authenticated-orcid":false,"given":"Samar S.","family":"Azab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2018.07.014_bb0005","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/08923973.2014.998368","article-title":"Anti-inflammatory and immunomodulatory effects of Spirulina platensis in comparison to Dunaliella salina in acetic acid-induced rat experimental colitis","volume":"37","author":"Abdel-Daim","year":"2015","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.taap.2018.07.014_bb0010","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1158\/1078-0432.CCR-06-2416","article-title":"Vascular endothelial growth factor and its relationship to inflammatory mediators","volume":"13","author":"Angelo","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2018.07.014_bb0015","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/eji.200939578","article-title":"Animal models of rheumatoid arthritis","volume":"39","author":"Asquith","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.taap.2018.07.014_bb0020","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/art.24781","article-title":"Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo","volume":"60","author":"Axmann","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.taap.2018.07.014_bb0025","series-title":"Theory and Practice of Histological Techniques","author":"Bancroft","year":"2008"},{"key":"10.1016\/j.taap.2018.07.014_bb0030","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.semarthrit.2013.07.008","article-title":"Effect of tocilizumab combined with methotrexate on circulating biomarkers of synovium, cartilage, and bone in the LITHE study","volume":"43","author":"Bay-Jensen","year":"2014","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.taap.2018.07.014_bb0035","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.3892\/mmr.2014.2070","article-title":"Anti-inflammatory effect of resveratrol on adjuvant arthritis rats with abnormal immunological function via the reduction of cyclooxygenase-2 and prostaglandin E2","volume":"9","author":"Chen","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.taap.2018.07.014_bb0040","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10067-008-1075-x","article-title":"Therapeutic effect of anti-vascular endothelial growth factor receptor I antibody in the established collagen-induced arthritis mouse model","volume":"28","author":"Choi","year":"2009","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.taap.2018.07.014_bb0045","doi-asserted-by":"crossref","DOI":"10.1136\/ard.62.suppl_2.ii68","article-title":"Interleukin 6 receptor as a target for the treatment of rheumatoid arthritis","volume":"62","author":"Choy","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.taap.2018.07.014_bb0050","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/art.21044","article-title":"Effects of combination M40403 and dexamethasone therapy on joint disease in a rat model of collagen-induced arthritis","volume":"52","author":"Cuzzocrea","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.taap.2018.07.014_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079284","article-title":"Targeting TNF-\u03b1 and NF-\u03baB activation by bee venom: role in suppressing adjuvant induced arthritis and methotrexate hepatotoxicity in rats","volume":"8","author":"Darwish","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2018.07.014_bb0060","first-page":"991","article-title":"Role of immune system, apoptosis and angiogenesis in pathogenesis of rheumatoid arthritis and joint destruction, a systematic review","volume":"85","author":"Dhaouadi","year":"2007","journal-title":"Tunis. Med."},{"key":"10.1016\/j.taap.2018.07.014_bb0065","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/annrheumdis-2011-201282","article-title":"Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)","volume":"72","author":"Dougados","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.taap.2018.07.014_bb0070","article-title":"Bone remodelling markers in rheumatoid arthritis","volume":"5","author":"Fardellone","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.taap.2018.07.014_bb0075","first-page":"2143","article-title":"Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium","volume":"149","author":"Firestein","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.taap.2018.07.014_bb0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/art.25053","volume":"62","author":"Garnero","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"229\u2013240","key":"10.1016\/j.taap.2018.07.014_bb0085","first-page":"w249","article-title":"Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial","volume":"151","author":"Goldbach-Mansky","year":"2009","journal-title":"Ann. Intern. Med."},{"issue":"Suppl. 2","key":"10.1016\/j.taap.2018.07.014_bb0090","first-page":"ii11","article-title":"Pathogenesis of bone and cartilage destruction in rheumatoid arthritis","volume":"42","author":"Goldring","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.taap.2018.07.014_bb0095","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1007\/s10753-014-0067-z","article-title":"Artesunate ameliorates functional limitations in Freund's complete adjuvant-induced Monoarthritis in rat by maintaining oxidative homeostasis and inhibiting COX-2 expression","volume":"38","author":"Guruprasad","year":"2015","journal-title":"Inflammation"},{"key":"10.1016\/j.taap.2018.07.014_bb0100","first-page":"440","volume":"67","author":"Hartmann","year":"2008","journal-title":"Z. Rheumatol."},{"key":"10.1016\/j.taap.2018.07.014_bb0105","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/rheumatology\/ken363","article-title":"IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17","volume":"47","author":"Hashizume","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.taap.2018.07.014_bb0110","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/sj.bjp.0704396","article-title":"Anti-inflammatory effect of synthetic somatostatin analogues in the rat","volume":"134","author":"Helyes","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2018.07.014_bb0115","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/eji.1830181122","article-title":"Excessive production of interleukin 6\/B cell stimulatory factor-2 in rheumatoid arthritis","volume":"18","author":"Hirano","year":"1988","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.taap.2018.07.014_bb0120","doi-asserted-by":"crossref","first-page":"E199","DOI":"10.36076\/ppj.2013\/16\/E199","article-title":"Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain condition","volume":"16","author":"Hua","year":"2013","journal-title":"Pain Physician"},{"key":"10.1016\/j.taap.2018.07.014_bb0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/14397595.2014.897793","volume":"25","author":"Izumi","year":"2015","journal-title":"Mod. Rheumatol."},{"issue":"11","key":"10.1016\/j.taap.2018.07.014_bb0130","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1136\/annrheumdis-2015-208426","article-title":"Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study)","volume":"75","author":"Kaneko","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.taap.2018.07.014_bb0135","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1365-2249.2000.01272.x","article-title":"Expression of vascular endothelial growth factor by synovial fluid neutrophils in rheumatoid arthritis (RA)","volume":"121","author":"Kasama","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.taap.2018.07.014_bb0140","article-title":"The effect of vascular endothelial growth factor on Osteoclastogenesis in rheumatoid arthritis","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2018.07.014_bb0145","article-title":"The effect of vascular endothelial growth factor on osteoclastogenesis in rheumatoid arthritis","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2018.07.014_bb0150","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/rheumatology\/keu302","article-title":"Importance of methotrexate therapy concomitant with tocilizumab treatment in achieving better clinical outcomes for rheumatoid arthritis patients with high disease activity: an observational cohort study","volume":"54","author":"Kojima","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.taap.2018.07.014_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077513","article-title":"Anti-angiogenic effect of triptolide in rheumatoid arthritis by targeting angiogenic cascade","volume":"8","author":"Kong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2018.07.014_bb0160","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/art.30158","volume":"63","author":"Kremer","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.taap.2018.07.014_bb0165","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3346\/jkms.2000.15.1.88","article-title":"Expression of cyclooxygenase-1 and -2 in rheumatoid arthritis synovium","volume":"15","author":"Lee","year":"2000","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.taap.2018.07.014_bb0170","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1021\/nn500685h","article-title":"Hyaluronate-gold nanoparticle\/tocilizumab complex for the treatment of rheumatoid arthritis","volume":"8","author":"Lee","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.taap.2018.07.014_bb0175","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1046\/j.1365-3083.1998.00399.x","article-title":"Synovial fluid cytokines in patients with rheumatoid arthritis or other arthritic lesions","volume":"48","author":"Lettesjo","year":"1998","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.taap.2018.07.014_bb0180","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.4049\/jimmunol.164.11.5922","article-title":"Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis","volume":"164","author":"Lu","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.taap.2018.07.014_bb0185","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3892\/br.2012.42","article-title":"TNF inhibitor therapy for rheumatoid arthritis","volume":"1","author":"Ma","year":"2013","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.taap.2018.07.014_bb0190","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/art.20268","article-title":"Increased interleukin-18 expression in bone marrow of a patient with systemic juvenile idiopathic arthritis and unrecognized macrophage-activation syndrome","volume":"50","author":"Maeno","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.taap.2018.07.014_bb0195","first-page":"39","article-title":"Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions","volume":"3","author":"Mahamid","year":"2011","journal-title":"Clin. Pharmacol."},{"key":"10.1016\/j.taap.2018.07.014_bb0200","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1002\/art.22033","article-title":"Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate","volume":"54","author":"Maini","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.taap.2018.07.014_bb0205","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2146\/ajhp060362","article-title":"Rheumatoid arthritis: a primer for pharmacists","volume":"63","author":"Marra","year":"2006","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.taap.2018.07.014_bb0210","first-page":"557","article-title":"Angiogenesis in rheumatoid arthritis","volume":"21","author":"Maruotti","year":"2006","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.taap.2018.07.014_bb0215","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2018.07.014_bb0220","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/003693308002500104","article-title":"Liver disease in rheumatoid arthritis","volume":"25","author":"Mills","year":"1980","journal-title":"Scott. Med. J."},{"key":"10.1016\/j.taap.2018.07.014_bb0225","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/01.LAB.0000022220.44511.40","article-title":"Study of the mechanism involved in angiogenesis and synovial cell proliferation in human synovial tissues of patients with rheumatoid arthritis using SCID mice","volume":"82","author":"Nagashima","year":"2002","journal-title":"Lab. Investig."},{"key":"10.1016\/j.taap.2018.07.014_bb0230","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nri846","article-title":"Apoptosis as a therapeutic tool in rheumatoid arthritis","volume":"2","author":"Pope","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"Suppl 1","key":"10.1016\/j.taap.2018.07.014_bb0235","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar2666","article-title":"Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review","volume":"11","author":"Rubbert-Roth","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.taap.2018.07.014_bb0240","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/rheumatology\/36.2.210","article-title":"Histologic liver abnormalities in an autopsy series of patients with rheumatoid arthritis","volume":"36","author":"Ruderman","year":"1997","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.taap.2018.07.014_bb0245","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2147\/OPTH.S107594","article-title":"Twelve-month outcomes in patients with retinal vein occlusion treated with low-frequency intravitreal ranibizumab","volume":"10","author":"Sakanishi","year":"2016","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.taap.2018.07.014_bb0250","first-page":"240","article-title":"Effect of direct angiogenesis inhibition in rheumatoid arthritis using a soluble vascular endothelial growth factor receptor 1 chimeric protein","volume":"29","author":"Sekimoto","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.taap.2018.07.014_bb0255","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(08)60453-5","article-title":"Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial","volume":"371","author":"Smolen","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2018.07.014_bb0260","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00393-012-1083-8","article-title":"Evaluation of complete Freund's adjuvant-induced arthritis in a Wistar rat model. Comparison of thermography and histopathology","volume":"72","author":"Snekhalatha","year":"2013","journal-title":"Z. Rheumatol."},{"key":"10.1016\/j.taap.2018.07.014_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100361","article-title":"Anti-TNF treatment response in rheumatoid arthritis patients is associated with genetic variation in the NLRP3-inflammasome","volume":"9","author":"Sode","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2018.07.014_bb0270","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1006\/bbrc.2001.4395","article-title":"Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice","volume":"281","author":"Sone","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.taap.2018.07.014_bb0275","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2174\/157339708786263942","article-title":"Targeting angiogenesis in rheumatoid arthritis","volume":"4","author":"Szekanecz","year":"2008","journal-title":"Curr. Rheumatol. Rev."},{"key":"10.1016\/j.taap.2018.07.014_bb0280","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.2741\/1657","article-title":"Angiogenesis in rheumatoid arthritis","volume":"10","author":"Szekanecz","year":"2005","journal-title":"Front. Biosci."},{"key":"10.1016\/j.taap.2018.07.014_bb0285","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/08916930903143083","article-title":"Angiogenesis in rheumatoid arthritis","volume":"42","author":"Szekanecz","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.taap.2018.07.014_bb0290","series-title":"Frontiers in bioscience","first-page":"44","article-title":"Chemokines and angiogenesis in rheumatoid arthritis","volume":"Vol. 1","author":"Szekanecz","year":"2009"},{"key":"10.1016\/j.taap.2018.07.014_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5312\/wjo.v4.i1.1","article-title":"Regulation of bone destruction in rheumatoid arthritis through RANKL-RANK pathways","volume":"4","author":"Tanaka","year":"2013","journal-title":"World J. Orthop."},{"key":"10.1016\/j.taap.2018.07.014_bb0300","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4065\/81.1.94","article-title":"Genetics of rheumatoid arthritis","volume":"81","author":"Turesson","year":"2006","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.taap.2018.07.014_bb0305","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1007\/s10753-013-9687-y","article-title":"Avastin exhibits therapeutic effects on collagen-induced arthritis in rat model","volume":"36","author":"Wang","year":"2013","journal-title":"Inflammation"},{"key":"10.1016\/j.taap.2018.07.014_bb0310","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0014-4800(03)00019-4","article-title":"The role of COX-2 in angiogenesis and rheumatoid arthritis","volume":"74","author":"Woods","year":"2003","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.taap.2018.07.014_bb0315","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.matbio.2008.06.005","article-title":"VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and beta3-integrin","volume":"27","author":"Yang","year":"2008","journal-title":"Matrix Biol."},{"key":"10.1016\/j.taap.2018.07.014_bb0320","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1006\/mthe.2002.0590","article-title":"Endostatin gene transfer inhibits joint angiogenesis and pannus formation in inflammatory arthritis","volume":"5","author":"Yin","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.taap.2018.07.014_bb0325","doi-asserted-by":"crossref","first-page":"129873","DOI":"10.1155\/2008\/129873","article-title":"Proinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: prospects for therapeutic intervention","volume":"2008","author":"Yoo","year":"2008","journal-title":"Mediat. Inflamm."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18303272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18303272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:45:54Z","timestamp":1758573954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X18303272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":65,"alternative-id":["S0041008X18303272"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2018.07.014","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative study of anti-VEGF Ranibizumab and Interleukin-6 receptor antagonist Tocilizumab in Adjuvant-induced Arthritis","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2018.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}